- CA$1.52bn
- CA$1.49bn
- CA$253.35m
- 97
- 68
- 58
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 85.3 | 47.6 | 97.4 | 105 | 139 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 7.84 | 18.3 | 1.45 | 18.4 | 3.44 |
Prepaid Expenses | |||||
Total Current Assets | 93.1 | 65.9 | 98.9 | 123 | 143 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,255 | 1,237 | 1,516 | 1,438 | 1,678 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.07 | 6.04 | 13.8 | 7.15 | 5.23 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 47.6 | 44.9 | 70.7 | 73.5 | 117 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 1,208 | 1,192 | 1,446 | 1,365 | 1,561 |
Total Liabilities & Shareholders' Equity | 1,255 | 1,237 | 1,516 | 1,438 | 1,678 |
Total Common Shares Outstanding |